Participating in clinical trials can benefit you most directly because you’re participating in a trial or research project where you otherwise wouldn’t have access to new treatments. But what’s good for you, also, may be good for lots of other people who, perhaps, couldn’t be involved in clinical research. But if a clinical trial is successful, and therefore we can demonstrate that in fact the treatment works, this could gain access and give access to lots of other people to get that experimental treatment once it’s improved.
Exploring the Secret to Saving Black Lives With Science 37
by Science 37
The Latest In Clinical Trials
A Doctor Explains What’s Missing From Black Clinical Trial Enrollment
Patient success takes a village, and Dr. Craig Cole of Karmanos Cancer Institute believes the village extends to the recruitment read more about A Doctor Explains What’s Missing From Black Clinical Trial Enrollment
Overcoming Tuskegee: How To Establish Black Trust in Clinical Trials
The Tuskegee Syphilis Experiment has left a painful legacy of medical mistrust in the Black American community. In the 1932-1972 read more about Overcoming Tuskegee: How To Establish Black Trust in Clinical Trials
Getting Blacks into Heart-Related Clinical Trials Isn’t a “Spectator Sport”
Despite progress in cardiovascular disease prevention and treatment, Black adults in the USA still face higher rates of premature CVD read more about Getting Blacks into Heart-Related Clinical Trials Isn’t a “Spectator Sport”
How Black Clinical Trial Participation Can End Health Care Inequalities
New medical treatments often come with great promise, but sometimes that promise doesn’t fully extend to Black Americans. “Populations of read more about How Black Clinical Trial Participation Can End Health Care Inequalities
Stage 4 Lung Cancer: Why I Said Yes to a Clinical Trial
In March 2020, Sheena P. was diagnosed with stage 4 lung cancer, which came as a huge shock to her read more about Stage 4 Lung Cancer: Why I Said Yes to a Clinical Trial
Why Blacks Aren’t Qualifying for Alzheimer’s Clinical Trials, And What Can Be Done About It
Despite the increased risk of Alzheimer’s disease, African Americans and Hispanics are underrepresented in clinical trials. A recent USC study read more about Why Blacks Aren’t Qualifying for Alzheimer’s Clinical Trials, And What Can Be Done About It